Immuneering Corp

IMRXNASDAQ · USD
4.44USD0.00 (-0.90%)
232

Immuneering Corp (IMRX) Implied Volatility Current

IMRX implied volatility is 93%. IV Rank is —%, placing current premiums in the middle of their 52-week range.

Read more

Tracking IMRX implied volatility helps you identify when options premiums on Immuneering Corp are historically cheap or expensive, and where the best trades are hiding. Immuneering Corp implied volatility reflects the market's expectation of future price movement: when IMRX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Immuneering Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMRX, tracking metrics like IMRX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMRX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMRX implied volatility sits today versus where it has been. Our scanner ranks Immuneering Corp implied volatility against its historical range, surfaces extremes in IMRX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Immuneering Corp IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
IV Rank
Implied Volatility (30d)93.27%

IV Rank

Historical Volatility (30d)48.99%

IV - HV+44.28%

As of September 18, 2026

Trade options with IV on your side

Track IMRX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial